查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1435120

API 中间体市场：按类型、原材料、应用和最终用户划分 - 全球预测 2024-2030

API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年API中间体市场规模为1,786.3亿美元，预估2024年将达1926.5亿美元，2030年将达3,032.3亿美元，复合年增长率为7.85%。

API中间体的全球市场

主要市场统计
基准年[2023] 1786.3亿美元
预测年份 [2024] 1926.5亿美元
预测年份 [2030] 3032.3亿美元
复合年增长率（%） 7.85%
API中间体市场-IMG1

API（活性药物成分）中间体是在 API 製造中充当构建模组的化合物。 API 是医药产品中发现的生物活性化合物，可以使製造的药物达到所需的治疗效果。 API 中间体在原料药製造的化学反应中充当起始材料或关键成分。确保原料药中间体的品质对于生产有效的药物是必要的，同时满足药物功效和安全性的监管标准。对原料药中间体的需求不断增长，这是由于慢性病的流行需要生产各种学名药，以及政府促进生物製药生产活动的努力。近年来，随着罕见疾病数量的增加，特殊原料药的生产变得越来越重要。然而，原料药中间体的复杂采购以及与维持原料药安全和品质相关的监管问题严重影响了市场的有效扩张。市场相关人员不断致力于推进API中间体的合成和加工方法，以确保更安全的生产方法。此外，专门从事原料药製造的受託製造厂商正在显着增加，为市场扩张创造了机会。此外，透过利用人工智慧（AI）和机器学习（ML）等数位技术的进步，可以更有效地预测新药的候选中间体并简化研究过程。

区域洞察

美洲市场的特点是API中间体相关研发活动的投资大幅增加。该地区领先的製药公司致力于透过併购、收购以及与致力于创新研究和改进技术的小公司建立伙伴关係来扩大其能力，以经济有效地生产复杂的原料药。由美国食品药物管理局(FDA) 和加拿大卫生署主导的严格法律规范确保 API 中间体的高品质标准。亚太地区凭藉其具有成本竞争力的製造能力，已成为 API 中间体市场的重要参与者。在促进药品出口的政​​府政策的推动下，推动这一成长的主要国家是印度和中国。该地区正致力于透过技术和培训投资以及主要企业之间的合作和原料药的批量生产来提高品质标准，以满足已开发地区不断增长的需求。欧洲传统上专注于化学合成来生产 API 中间体，使其在有机合成化学製程方面保持强大的专业知识。德国、英国等成熟市场的特点是欧洲药品管理局 (EMA) 执行严格的法规，确保高品质标准。欧洲公司正在利用现有基础设施和熟练劳动力的优势来吸引全球客户进行原料药中间体製造，从而增强该地区充满活力的合约研究和受託製造服务 (CRAMS) 生态系统。

FPNV定位矩阵

FPNV定位矩阵对于评估API中间体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对 API 中间体市场中供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-API中间体市场的市场规模与预测是多少？

2-API中间体市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-API中间体市场的技术趋势与法律规范是什么？

4-API中间体市场主要供应商的市场占有率是多少？

5-进入API中间体市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行和对学名药的需求
      • 政府促进生物製药生产活动的倡议
      • 越来越多地采用罕见疾病和用于治疗罕见疾病的特殊原料药
    • 抑制因素
      • API 中间体的复杂采购与智慧财产权问题
    • 机会
      • API中间体的合成与加工研究进展
      • 专门从事原料药製造的契约製造组织的兴起
    • 任务
      • API 中间体安全与品质的监管复杂性
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 API 中间体市场：依类型

  • 原料药中间体
  • 化学中间体

第七章原料药中间体市场：依原料分类

  • 羰
  • 库洛洛
  • 丁腈橡胶
  • 硝基

第八章原料药中间体市场：依应用分类

  • 止痛药
  • 感染疾病
  • 抗癌剂
  • 抗糖尿病药
  • 心血管药物

第 9 章 API 中间体市场：依最终使用者划分

  • 生物技术和製药公司
  • CMO
  • 调查

第十章 美洲原料药中间体市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太原料药中间体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东及非洲原料药中间体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 併购
    • 投资、资金筹措
    • 奖项/奖励/扩展

第14章竞争产品组合

  • 主要公司简介
    • Aarti Pharmalabs Limited
    • Actylis
    • Alzchem Group
    • API Corporation by UBE Corp.
    • Atul Ltd.
    • Aurobindo Pharma
    • BASF SE
    • Cambrex Corp.
    • Cation Pharma
    • Divi's Laboratories Limited
    • Dr. Reddy's Laboratories Ltd.
    • Espee Group
    • Evonik Industries AG
    • Flamma Group
    • Hikal Ltd.
    • Kaneka Corporation
    • Levachem Company Ltd.
    • Lupin Ltd.
    • Nectar Lifesciences Ltd.
    • Noah Chemicals
    • Pfizer Inc.
    • Proviron Holding NV
    • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • Sandoz International GmbH by Novartis AG
    • Sanofi
    • Sarex
    • Shree Ganesh Remedies Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Vertellus
    • ZCL Chemicals Ltd. by Advent International
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-CF699CF4142B

[199 Pages Report] The API Intermediates Market size was estimated at USD 178.63 billion in 2023 and expected to reach USD 192.65 billion in 2024, at a CAGR 7.85% to reach USD 303.23 billion by 2030.

Global API Intermediates Market

KEY MARKET STATISTICS
Base Year [2023] USD 178.63 billion
Estimated Year [2024] USD 192.65 billion
Forecast Year [2030] USD 303.23 billion
CAGR (%) 7.85%
API Intermediates Market - IMG1

API (Active Pharmaceutical Ingredients) intermediates are chemical compounds that cater as building blocks in the production of APIs. APIs are biologically active compounds in pharmaceutical drugs that enable the desired therapeutic effect of the drug produced. API intermediates act as the starting materials or key components in the chemical reactions that lead to the making of APIs. Ensuring the quality of API intermediates is necessary to create an effective medication while meeting the regulatory standards for drug efficacy and safety. The expanding need for API intermediates has been driven by the prevalence of chronic diseases demanding the production of various generic drugs and government initiatives promoting biopharmaceutical manufacturing activities. With the rise in cases of orphan and rare diseases, recent years have observed an increasing emphasis on the manufacturing of specialty APIs. However, complicated sourcing of API intermediates and regulatory concerns associated with maintaining the safety and quality of APIs significantly impact the efficient expansion of the market. Market players are constantly working on elevating the synthesizing and processing methods of API intermediates to ensure a safer production method. There has also been a major increase in the number of contract manufacturing organizations specializing in API production, which has created better opportunities for market enlargement. Moreover, leveraging advances in digital technologies such as artificial intelligence (AI) and machine learning (ML) could also help streamline research processes by predicting potential intermediates for novel drugs more effectively.

Regional Insights

The Americas market is characterized by a substantial increase in investments toward R&D activities related to the API intermediates. Major regional pharmaceutical companies focus on expanding their capabilities through mergers, acquisitions, or collaborations with smaller firms engaged in innovative research and in technology upgradation for the cost-effective production of complex APIs. Strict regulatory frameworks led by the U.S. Food & Drug Administration (FDA) in the United States and Health Canada in Canada ensure high-quality standards for API intermediates. APAC has emerged as a vital player in the API intermediates market due to its cost-competitive manufacturing capabilities. Major countries contributing to this growth are India and China, with supportive government policies that promote pharmaceutical exports. The region also witnesses collaborations among key players or bulk API production while focusing on improving quality standards through investments in technology and training to capture growing demand in developed regions. Europe has been traditionally focusing on chemical synthesis for producing API intermediates which enables them to maintain strong expertise in synthetic organic chemistry processes. Mature markets such as Germany, France, and the United Kingdom are characterized by strict regulations governed by the European Medicines Agency (EMA), ensuring high-quality standards. European companies are leveraging the advantages of their well-established infrastructure and skilled workforce to attract global clients for API intermediate manufacturing, leading to the emergence of a vibrant contract research and manufacturing services (CRAMS) ecosystem in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the API Intermediates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the API Intermediates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the API Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aarti Pharmalabs Limited, Actylis, Alzchem Group, API Corporation by UBE Corp., Atul Ltd., Aurobindo Pharma, BASF SE, Cambrex Corp., Cation Pharma, Divi's Laboratories Limited, Dr. Reddy's Laboratories Ltd., Espee Group, Evonik Industries AG, Flamma Group, Hikal Ltd., Kaneka Corporation, Levachem Company Ltd., Lupin Ltd., Nectar Lifesciences Ltd., Noah Chemicals, Pfizer Inc., Proviron Holding NV, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Sandoz International GmbH by Novartis AG, Sanofi, Sarex, Shree Ganesh Remedies Ltd., Sumitomo Chemical Co., Ltd., Vertellus, and ZCL Chemicals Ltd. by Advent International.

Market Segmentation & Coverage

This research report categorizes the API Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bulk Drug Intermediates
    • Chemical Intermediates
  • Raw Material
    • Carbonyl
    • Chloro
    • Nitrile
    • Nitro
  • Application
    • Analgesics
    • Anti-Infective Drugs
    • Anticancer Drugs
    • Antidiabetic Drugs
    • Cardiovascular Drugs
  • End User
    • Biotech & Pharmaceutical Companies
    • CMO
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the API Intermediates Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the API Intermediates Market?

3. What are the technology trends and regulatory frameworks in the API Intermediates Market?

4. What is the market share of the leading vendors in the API Intermediates Market?

5. Which modes and strategic moves are suitable for entering the API Intermediates Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. API Intermediates Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for generic drugs
      • 5.1.1.2. Government initiatives promoting biopharmaceutical manufacturing activities
      • 5.1.1.3. Increased adoption of specialty APIs for rare and orphan disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated sourcing of API intermediates and intellectual property concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in synthesizing and processing of API intermediates
      • 5.1.3.2. Rise of contract manufacturing organizations specializing in API production
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory complexity concerning the safety and quality of API intemediates
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. API Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. Bulk Drug Intermediates
  • 6.3. Chemical Intermediates

7. API Intermediates Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Carbonyl
  • 7.3. Chloro
  • 7.4. Nitrile
  • 7.5. Nitro

8. API Intermediates Market, by Application

  • 8.1. Introduction
  • 8.2. Analgesics
  • 8.3. Anti-Infective Drugs
  • 8.4. Anticancer Drugs
  • 8.5. Antidiabetic Drugs
  • 8.6. Cardiovascular Drugs

9. API Intermediates Market, by End User

  • 9.1. Introduction
  • 9.2. Biotech & Pharmaceutical Companies
  • 9.3. CMO
  • 9.4. Research Laboratories

10. Americas API Intermediates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific API Intermediates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa API Intermediates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Sigachi Industries Forays into API business, Acquires Majority Stake in Trimax Bio Sciences
    • 13.3.2. Investment & Funding
      • 13.3.2.1. FLAMMA to Invest USD 200 Million Over the Next 3 Years
    • 13.3.3. Award, Recognition, & Expansion
      • 13.3.3.1. Boehringer Ingelheim and German Chancellor Olaf Scholz Lay The Foundation Stone for 285 million EUR Innovation Center

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Aarti Pharmalabs Limited
    • 14.1.2. Actylis
    • 14.1.3. Alzchem Group
    • 14.1.4. API Corporation by UBE Corp.
    • 14.1.5. Atul Ltd.
    • 14.1.6. Aurobindo Pharma
    • 14.1.7. BASF SE
    • 14.1.8. Cambrex Corp.
    • 14.1.9. Cation Pharma
    • 14.1.10. Divi's Laboratories Limited
    • 14.1.11. Dr. Reddy's Laboratories Ltd.
    • 14.1.12. Espee Group
    • 14.1.13. Evonik Industries AG
    • 14.1.14. Flamma Group
    • 14.1.15. Hikal Ltd.
    • 14.1.16. Kaneka Corporation
    • 14.1.17. Levachem Company Ltd.
    • 14.1.18. Lupin Ltd.
    • 14.1.19. Nectar Lifesciences Ltd.
    • 14.1.20. Noah Chemicals
    • 14.1.21. Pfizer Inc.
    • 14.1.22. Proviron Holding NV
    • 14.1.23. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • 14.1.24. Sandoz International GmbH by Novartis AG
    • 14.1.25. Sanofi
    • 14.1.26. Sarex
    • 14.1.27. Shree Ganesh Remedies Ltd.
    • 14.1.28. Sumitomo Chemical Co., Ltd.
    • 14.1.29. Vertellus
    • 14.1.30. ZCL Chemicals Ltd. by Advent International
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. API INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. API INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. API INTERMEDIATES MARKET DYNAMICS
  • FIGURE 7. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 10. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. API INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. API INTERMEDIATES MARKET SIZE, BY BULK DRUG INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. API INTERMEDIATES MARKET SIZE, BY CHEMICAL INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 9. API INTERMEDIATES MARKET SIZE, BY CARBONYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. API INTERMEDIATES MARKET SIZE, BY CHLORO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. API INTERMEDIATES MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. API INTERMEDIATES MARKET SIZE, BY NITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. API INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. API INTERMEDIATES MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. API INTERMEDIATES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. API INTERMEDIATES MARKET SIZE, BY ANTIDIABETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. API INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. API INTERMEDIATES MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. API INTERMEDIATES MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. API INTERMEDIATES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. API INTERMEDIATES MARKET LICENSE & PRICING